MA42521A - Système d'administration transdermique - Google Patents

Système d'administration transdermique

Info

Publication number
MA42521A
MA42521A MA042521A MA42521A MA42521A MA 42521 A MA42521 A MA 42521A MA 042521 A MA042521 A MA 042521A MA 42521 A MA42521 A MA 42521A MA 42521 A MA42521 A MA 42521A
Authority
MA
Morocco
Prior art keywords
delivery system
transdermal delivery
transdermal
delivery
Prior art date
Application number
MA042521A
Other languages
English (en)
French (fr)
Inventor
Deborah Phyllis Harding
Helen Johnson
Gill Mundin
Kevin Smith
Steve Whitelock
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MA42521A publication Critical patent/MA42521A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA042521A 2015-07-30 2016-07-28 Système d'administration transdermique MA42521A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1513441.4A GB201513441D0 (en) 2015-07-30 2015-07-30 Transdermal delivery system

Publications (1)

Publication Number Publication Date
MA42521A true MA42521A (fr) 2018-06-06

Family

ID=54062902

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042521A MA42521A (fr) 2015-07-30 2016-07-28 Système d'administration transdermique

Country Status (16)

Country Link
US (1) US20180221299A1 (enExample)
EP (1) EP3328431A1 (enExample)
JP (1) JP2018528175A (enExample)
KR (1) KR20180035859A (enExample)
CN (1) CN108025077A (enExample)
AR (1) AR105533A1 (enExample)
AU (1) AU2016298761A1 (enExample)
BR (1) BR112018001615A2 (enExample)
CA (1) CA2994103A1 (enExample)
GB (1) GB201513441D0 (enExample)
IL (1) IL256995A (enExample)
MA (1) MA42521A (enExample)
MX (1) MX2018001318A (enExample)
SG (1) SG10201913254RA (enExample)
TW (1) TW201713340A (enExample)
WO (1) WO2017017452A1 (enExample)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
CL2004000927A1 (es) * 2003-04-30 2005-01-28 Purdue Pharma Lp Forma de dosificacion transdermica que comprende un agente activo, una superficie proxima y una superficie distal.
TWI541246B (zh) * 2008-12-08 2016-07-11 歐陸斯迪公司 二氫羥戊甲嗎啡

Also Published As

Publication number Publication date
EP3328431A1 (en) 2018-06-06
CN108025077A (zh) 2018-05-11
US20180221299A1 (en) 2018-08-09
AR105533A1 (es) 2017-10-11
BR112018001615A2 (pt) 2018-09-18
SG10201913254RA (en) 2020-03-30
GB201513441D0 (en) 2015-09-16
KR20180035859A (ko) 2018-04-06
JP2018528175A (ja) 2018-09-27
WO2017017452A1 (en) 2017-02-02
MX2018001318A (es) 2018-08-15
IL256995A (en) 2018-03-29
AU2016298761A1 (en) 2018-02-15
CA2994103A1 (en) 2017-02-02
TW201713340A (zh) 2017-04-16

Similar Documents

Publication Publication Date Title
EP3297620A4 (en) TRANSDERMAL DELIVERY SYSTEM FOR KETAMINE
EP3380061A4 (en) AUTOMATED WEARABLE DRUG DELIVERY SYSTEM
EP3435978A4 (en) RELEASE SYSTEM
EP3389557A4 (en) Transseptal delivery system
EP3294398A4 (en) SYSTEM AND METHOD FOR THE ADMINISTRATION OF MEDICAMENTS
DK3368108T3 (da) Medikamenttilførselsanordning
EP3589341A4 (en) REMOTE DRUG DELIVERY SYSTEM
EP3349670A4 (en) SOLUBLE RELEASE SYSTEM
DK3302638T3 (da) Anordning til indgivelse af lægemidler
EP3346998A4 (en) SYSTEM FOR DISTRIBUTING A TOPICAL FILM
EP3302087A4 (en) BREWING SYSTEM
EP3231467C0 (en) INFUSION PUMP SYSTEM
DK3380139T3 (da) Medikamentadministrationsanordning
EP3445416A4 (en) ENTERALES ACTIVE COMPOSITION SYSTEM
EP3373908A4 (en) SYSTEMS FOR RELEASING A PROBIOTIC
EP3348648A4 (en) VEHICLES FOR INTRA-CELLULAR RELEASE
DK3380146T3 (da) Medikamentadministrationsanordning
DK3558438T3 (da) Lægemiddelindgivelsesanordning
DK3558423T3 (da) Medikamentadministrationsanordning
EP3244868C0 (en) DRUG DELIVERY DEVICES
EP3354128A4 (en) IRRIGATION SYSTEM
DK3570911T3 (da) Medikamenttilførselsanordning
EP3359994A4 (en) SELF-DRIVE SYSTEM
DK3288955T3 (da) Bortezomib-baseret afgivelsessystem
EP3334413A4 (en) DISPENSER